Dernières nouvelles

Information non disponible

Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T,

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

Article de revue

N Engl J Med, 390 (15), 2024.

Résumé | Liens:

Heymach JV, Harpole D, Mitsudomi T, Taube JM, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M,

Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer

Article de revue

N Engl J Med, 389 (18), 2023.

Résumé | Liens:

Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, , Arnold DM

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Article de revue

Nat Med, 27 (11), 2021.

Résumé | Liens:

Patriquin CJ, Kiss T, Caplan S, Chin-Yee I, Grewal K, Grossman J, Larratt L, Marceau D, Nevill T, Sutherland DR, Wells RA, Leber B

How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry

Article de revue

Eur J Haematol, 102 (1), 2019.

Résumé | Liens:

Bordeleau S, Poitras J, Marceau D, Breton C, Beaupre P, Archambault PM

Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays

Article de revue

BMC Health Serv Res, 15 , 2015.

Résumé | Liens:

Yan J, Marceau D, Drouin R

Tetrasomy 8 is associated with a major cellular proliferative advantage and a poor prognosis. two cases of myeloid hematologic disorders and review of the literature

Article de revue

Cancer Genet Cytogenet, 125 (1), 2001.

Résumé | Liens:

Signaler des ajouts ou des modifications